DNA priming and gp120 boosting induces HIV-specific antibodies in a randomized clinical trial.

At 2 weeks after the fourth vaccination, the CD4 + T cell response rate to Env ranged from 36% to 60% among the 4 groups, with the highest response rate in T3, but the differences did not reach statistical significance ( Figure 8A ).

also in 111,027 other papers